Jay Philip Siegel - 31 May 2023 Form 4 Insider Report for MACROGENICS INC (MGNX)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MGNX	Stock Option (right to buy)	Award	$0	+19,000	$0.000000	19,000	31 May 2023	Common Stock	19,000	$4.67	Direct	F1
transaction	MGNX	Restricted Stock Unit	Award	$0	+4,500	$0.000000	4,500	31 May 2023	Common Stock	4,500	$0.000000	Direct	F2, F3
transaction	MGNX	Stock Option (right to buy)	Award	$0	+21,490	$0.000000	21,490	31 May 2023	Common Stock	21,490	$4.67	Direct	F1, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards for whole shares) beginning one month from the date of grant.
F2	Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer?s Common Stock. The RSU grant was approved by the Issuer?s Board of Directors on May 31, 2023 and will be effective as of the date the Issuer has an effective Registration Statement on Form S-8 registering the shares available for issuance under the 2023 Equity Incentive Plan.
F3	The RSUs will vest one year after the date of grant, or the day prior to the next annual meeting, if earlier
F4	At the election of the filing person, the option grant is issued in lieu of direct cash compensation of such person's annual retainer through the Company's non-employee director compensation program and will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards to whole shares) beginning one month from the date of grant.